(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation. [electronic resource]
Producer: 20121025Description: 723-31 p. digitalISSN:- 1432-2277
- Adult
- Antiviral Agents -- therapeutic use
- Chemoprevention -- methods
- Child
- Cohort Studies
- Epstein-Barr Virus Infections -- prevention & control
- Female
- Ganciclovir -- analogs & derivatives
- Herpesvirus 4, Human -- metabolism
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- methods
- Lymphoproliferative Disorders -- etiology
- Male
- Pediatrics -- methods
- Prospective Studies
- Valganciclovir
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.